Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.
about
Altered Calcium Handling and Ventricular Arrhythmias in Acute IschemiaMetabolic cardiomyopathies.Downregulation of carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretionProphylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulationBay K 8644, modifier of calcium transport and energy metabolism in rat heart mitochondria: a new intracellular site of action.Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years ExperienceCardiac metabolism in heart failure: implications beyond ATP production.L-Carnitine for the treatment of a calcium channel blocker and metformin poisoning.Antagonists and activators at calcium channels. Effects in the gastrointestinal tract.Alpha-adrenoceptors: a critical review.Activators and inactivators of calcium channels: effects in the central nervous system.Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.Recent insights pertaining to sarcolemmal phospholipid alterations underlying arrhythmogenesis in the ischemic heart.The effects of novel vasodilator long chain acyl carnitine esters in the isolated perfused heart of the rat.Interactions of palmitoyl carnitine with the endothelium in rat aorta.Interaction of palmitoyl carnitine with calcium antagonists in myocytes.Palmitoyl-DL-carnitine has calcium-dependent effects on cultured neurones from rat dorsal root ganglia.Effects of some L-carnitine derivatives on heart membrane ATPases.Isolation and characterization of a fraction from brain that inhibits 1,4-[3H]dihydropyridine binding and L-type calcium channel current.Identification of ascorbate as an endogenous substance that irreversibly inhibits binding of dihydropyridine calcium channel blockers.Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis.l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
P2860
Q28067531-84DCBFFD-2BAD-4750-B343-E67B97094695Q34216280-1B4FCF9C-6DA7-4A29-864D-E1EEFDBA075DQ34393337-4721204E-455F-4903-8DD0-24603426721CQ34568583-6D1278EB-8AAA-46D0-9455-F45605F1CB7EQ35888227-96E37626-AADB-4E09-A526-AAFBEBDBC57AQ36461753-89A9C62D-6576-4EA5-9792-24F5DF5D4E82Q37495811-2CDC731D-2EB4-43B9-B41F-BF55C138F428Q38103466-B9CECF8B-F60B-469F-9097-471148A28B6EQ38188968-542B0292-4A83-4836-8FC5-AE34EC1102AEQ38300649-704DAF8F-8F37-4704-B496-12FD291FB870Q38318849-4A93C51C-CF22-4805-AAEF-E25FB2C6C21AQ39321549-8D439D8D-41F5-498C-B5C9-B8CC0DD5E909Q40795013-C6CCE41D-9538-4359-83E3-A2CF7CD9D36EQ42004450-5FDBD57D-64D2-410F-8842-53ED4E126DBBQ42076902-8D46D6F0-34CF-43C4-8110-F698A9D4C8CFQ42225316-7DE1C941-02E1-43AC-B280-EE74BF93E0BBQ42715564-90880BDC-5402-4B01-AA18-15AC974B34DDQ44577355-4A9A68FD-F117-4BF4-818D-DC02ADEFF4EAQ45292118-985FFFA2-98A6-466F-9566-C936FCE5AE4AQ48498968-E83C50FC-678C-43CE-A76F-0FE9545A519FQ53009453-1191CECF-5915-493D-9791-D35299207D50Q56504222-CCA13478-4177-4EED-8552-5CFFE474E229
P2860
Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.
@en
type
label
Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.
@en
prefLabel
Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.
@en
P2860
P1476
Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1987.TB11343.X
P407
P577
1987-10-01T00:00:00Z